Submitting the form, please do not close the page and
ensure that your network is smooth to avoid the email being unable to be sent.


CAGR of 10.6%
Seize the dermal fillers market!


The global hyaluronic acid-based dermal fillers makretsize was valued at USD 3.67 billion in 2022 and is expected to grow at CAGR of 10.6% from 2023 to 2030.

dermal filler injection-07
dermal filler injection-06

Why fill with Formaderm®?

1. Long-lasting, High Viscoelasticity


ECHA™ balanced cross-linking technology uses a special equalization device to unwind the tangled hyaluronic acid molecule chain and evenly disperse the cross-linking agent BDDE, resulting in a filler with uniform cross-linking, excellent viscoelasticity, and longevity.

dermal filler injection-08

2. Safety first, allergy-free


Formaderm features medical-grade hyaluronic acid from non-animal sources, which is highly biocompatible, ensuring high stability and eliminating the risks of diseases and contamination.

dermal filler injection-11
dermal filler injection-12

$1.65 M Clinical efficacy and safety:

Investing $1.65 million in clinical trials with comparable efficacy to the leading brand. Natural results immediately after injection with no adverse reactions.

<0.02% Ultra-low protein content:

Raw material inspection results <0.02% to ensure the safety of use. (Regulatory Standards <0.3%)

<0.125 ppm Low BDDE residue:

WASH purification process effectively eliminates excess impurities, reducing the residual BDDE cross-linking agent to near zero (<0.125 ppm).

3. Superior comfort, superior satisfaction


Comfortable injection experience (injection thrust < 20N): This feature enhances the safety and predictability of the injection procedure, providing a more comfortable and controlled injection experience for both physicians and patients during injection.

Quick results !

Partners with MBI